1. Home
  2. WVE vs VAC Comparison

WVE vs VAC Comparison

Compare WVE & VAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • VAC
  • Stock Information
  • Founded
  • WVE 2012
  • VAC 1984
  • Country
  • WVE Singapore
  • VAC United States
  • Employees
  • WVE N/A
  • VAC N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • VAC Real Estate
  • Sector
  • WVE Health Care
  • VAC Finance
  • Exchange
  • WVE Nasdaq
  • VAC Nasdaq
  • Market Cap
  • WVE 2.4B
  • VAC 2.7B
  • IPO Year
  • WVE 2015
  • VAC N/A
  • Fundamental
  • Price
  • WVE $13.67
  • VAC $91.24
  • Analyst Decision
  • WVE Strong Buy
  • VAC Buy
  • Analyst Count
  • WVE 10
  • VAC 10
  • Target Price
  • WVE $21.30
  • VAC $98.05
  • AVG Volume (30 Days)
  • WVE 1.4M
  • VAC 449.9K
  • Earning Date
  • WVE 11-12-2024
  • VAC 11-06-2024
  • Dividend Yield
  • WVE N/A
  • VAC 3.33%
  • EPS Growth
  • WVE N/A
  • VAC N/A
  • EPS
  • WVE N/A
  • VAC 5.26
  • Revenue
  • WVE $53,610,000.00
  • VAC $3,194,000,000.00
  • Revenue This Year
  • WVE N/A
  • VAC $54.30
  • Revenue Next Year
  • WVE N/A
  • VAC $4.79
  • P/E Ratio
  • WVE N/A
  • VAC $17.36
  • Revenue Growth
  • WVE N/A
  • VAC N/A
  • 52 Week Low
  • WVE $3.50
  • VAC $67.28
  • 52 Week High
  • WVE $16.74
  • VAC $108.57
  • Technical
  • Relative Strength Index (RSI)
  • WVE 50.96
  • VAC 65.72
  • Support Level
  • WVE $14.95
  • VAC $77.02
  • Resistance Level
  • WVE $16.71
  • VAC $94.94
  • Average True Range (ATR)
  • WVE 1.04
  • VAC 3.15
  • MACD
  • WVE -0.28
  • VAC 0.90
  • Stochastic Oscillator
  • WVE 14.72
  • VAC 62.15

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About VAC Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.

Share on Social Networks: